Avita Medical Limited, a medical technology company, develops and distributes regenerative and tissue-engineered products. The company's regenerative and tissue-engineered products provide solutions utilizing the patient's own skin and the regenerative capability of the human body to treat a range of wounds, scars, and skin defects. Its product line includes ReCell, a rapid cell harvesting device that enables surgeons to treat skin defects using the patient's cells. The company also manufactures and sells a range of spacers, including Funhaler, an asthma spacer for the paediatric market; and Breath-A-Tech spacer for the adolescent and adult markets. It markets its products primarily in the Asia Pacific, Europe, the Middle East, Africa, and the Americas. The company is headquartered in Cambridge, the United Kingdom.